7-cyclopentyl-N-(4-methoxyphenyl)-2-(5-(piperazin-1-yl)pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide

ID: ALA4782842

PubChem CID: 162665138

Max Phase: Preclinical

Molecular Formula: C28H32N8O2

Molecular Weight: 512.62

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(NC(=O)c2cc3cnc(Nc4ccc(N5CCNCC5)cn4)nc3n2C2CCCC2)cc1

Standard InChI:  InChI=1S/C28H32N8O2/c1-38-23-9-6-20(7-10-23)32-27(37)24-16-19-17-31-28(34-26(19)36(24)21-4-2-3-5-21)33-25-11-8-22(18-30-25)35-14-12-29-13-15-35/h6-11,16-18,21,29H,2-5,12-15H2,1H3,(H,32,37)(H,30,31,33,34)

Standard InChI Key:  FNAZUFVXFZSHAN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
    8.1964  -12.2275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9102  -11.8181    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.9074  -10.9913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1946  -10.5819    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4842  -11.8186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4854  -10.9979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7051  -10.7444    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2200  -11.4043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7032  -12.0697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3987  -11.4031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9911  -10.6948    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9891  -12.1144    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6135  -10.5759    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3269  -10.9860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1678  -12.1132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4523   -9.9656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9336   -9.3011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4543   -8.6351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6725   -8.8865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6714   -9.7078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7592  -11.4022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9386  -11.4006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5282  -12.1124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9402  -12.8272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7594  -12.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3266  -11.8050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0392  -12.2108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7504  -11.7995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7447  -10.9740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0316  -10.5677    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4642  -12.2042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4664  -13.0265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1763  -13.4355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8884  -13.0226    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.8862  -12.2004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1719  -11.7910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7110  -12.1123    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3023  -12.8200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  8 10  1  0
 10 11  2  0
 10 12  1  0
  3 13  1  0
 13 14  1  0
 12 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 16  1  0
  7 16  1  0
 15 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 15  1  0
 14 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 14  1  0
 31 32  1  0
 31 36  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 28 31  1  0
 23 37  1  0
 37 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4782842

    ---

Associated Targets(Human)

BXPC-3 (2997 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCND1 Tchem CDK6/cyclin D1 (322 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK4 Tclin Cyclin-dependent kinase 4/cyclin D1 (2340 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MIA PaCa-2 (5949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 512.62Molecular Weight (Monoisotopic): 512.2648AlogP: 4.36#Rotatable Bonds: 7
Polar Surface Area: 109.23Molecular Species: BASEHBA: 9HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.56CX Basic pKa: 8.86CX LogP: 4.02CX LogD: 2.54
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.34Np Likeness Score: -1.38

References

1. Shi X,Quan Y,Wang Y,Wang Y,Li Y.  (2021)  Design, synthesis, and biological evaluation of 2,6,7-substituted pyrrolo[2,3-d]pyrimidines as cyclin dependent kinase inhibitor in pancreatic cancer cells.,  33  [PMID:33316409] [10.1016/j.bmcl.2020.127725]

Source